Skip to main content
. 2017 Aug 16;8(44):77963–77974. doi: 10.18632/oncotarget.20276

Table 3. The joint effect of the two SNPs.

Stratum Model* Cases HR 95% CI P value
Smokers 0 39 1.00
1 71 1.29 0.83–2.00 0.252
2 67 1.66 1.07–2.59 0.024
3 + 4 25 3.00 1.75–5.13 < 0.001
AD 0 48 1.00
1 85 1.24 0.93–1.86 0.289
2 68 1.30 0.85–1.98 0.226
3 + 4 36 2.20 1.35–3.58 0.001
SQU 0 26 1.00
1 58 0.84 0.51–1.40 0.505
2 58 1.64 0.99–2.72 0.054
3 + 4 22 1.85 1.01–3.39 0.047
III/IV 0 47 1.00
1 108 1.22 0.85–1.75 0.290
2 107 1.53 1.06–2.19 0.023
3 + 4 41 2.00 1.30–3.09 0.002
Chemotherapy 0 80 1.00
1 154 1.15 0.85–1.55 0.364
2 138 1.41 1.04–1.91 0.029
3 + 4 60 1.67 1.16–2.41 0.006

*0:AA of microRNA 30c-1 polymorphisms and TT of microRNA 27a polymorphisms, 1: AG of microRNA 30c-1 polymorphisms and TT of microRNA 27a polymorphisms, or AA of microRNA 30c-1 polymorphisms and CT of microRNA 27a polymorphisms, 2: GG of microRNA 30c-1 polymorphisms and TT of microRNA 27a polymorphisms, or AA of microRNA 30c-1 polymorphisms and CC of microRNA 27a polymorphisms, or AG of microRNA 30c-1 polymorphisms and CT of microRNA 27a polymorphisms, 3: AG of microRNA 30c-1 polymorphisms and CC of microRNA 27a polymorphisms, or GG of microRNA 30c-1 polymorphisms and CT of microRNA 27a polymorphisms, 4:AA of microRNA 30c-1 polymorphisms and CC of microRNA 27a polymorphisms.